Arg257Cys polymorphism of CYP2A13 in a Chinese population

被引:14
作者
Cheng, XY
Chen, GL
Zhang, WX
Zhou, G
Wang, D
Zhou, HH [1 ]
机构
[1] Cent S Univ, Inst Clin Pharmacol, Pharmacogent Res Inst, Changsha 410078, Hunan, Peoples R China
[2] Cent S Univ, Coll Chem & Chem Engnieer, Changsha 410083, Peoples R China
关键词
cytochrome P450; CYP2A13; genetic polymorphism; genotype; Chinese;
D O I
10.1016/j.cccn.2004.01.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Background: Human cytochrome P450 2A13 (CYP2A13) is involved in the activation of numerous toxicants and carcinogens, especially in the metabolic activation of 4-(methyl-nitrosamino)-1-(3 -pyridyl)-1-butanone (NNK), a major tobacco-specific carcinogen. A functionally significant coding single nucleotide polymorphisin (C3375T) in exon 5 of CYP2A13, which results in an amino acid substitution of Arg 257 to Cys, has been recently reported to exist in White, Black, Hispanic, and Asian individuals, with the variant 3375T allele frequencies being 1.9%, 14.4%, 5.8% and 7.7%, respectively. Since genetic background differs between ethnic groups, our present study aims to characterize the CYP2A13 Arg257Cys polymorphism in Chinese. Methods: 258 healthy Chinese Han volunteers were involved in this study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was employed to genotype for the Arg257Cys polymorphism. Results: Of all the 258 subjects, 27 (10.5%) heterozygotes and 1 (0.4%) homozygote for the 257Cys allele were detected. The frequency of the variant 257Cys allele in this Chinese population was 5.6% (95%CI: 4.2-7.0%). Conclusion: The CYP2A13 Arg257Cys variant represents a common polymorphisin in Chinese, with the 257Cys allele frequency being similar to the Hispanic and Asian groups, but significantly lower than the Black. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 15 条
[1]
[Anonymous], 1989, Molecular Cloning: A Laboratory Manual
[2]
THE CYP 2A GENE SUBFAMILY - SPECIES-DIFFERENCES, REGULATION, CATALYTIC ACTIVITIES AND ROLE IN CHEMICAL CARCINOGENESIS [J].
FERNANDEZSALGUERO, P ;
GONZALEZ, FJ .
PHARMACOGENETICS, 1995, 5 :S123-S128
[3]
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
[4]
GOTOH O, 1992, J BIOL CHEM, V267, P83
[5]
STRUCTURE AND FUNCTION OF CYTOCHROMES-P450 - A COMPARATIVE-ANALYSIS OF 3 CRYSTAL-STRUCTURES [J].
HASEMANN, CA ;
KURUMBAIL, RG ;
BODDUPALLI, SS ;
PETERSON, JA ;
DEISENHOFER, J .
STRUCTURE, 1995, 3 (01) :41-62
[7]
Tobacco smoke carcinogens and lung cancer [J].
Hecht, SS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) :1194-1210
[8]
Hecht SS, 1997, P SOC EXP BIOL MED, V216, P181
[9]
Liu C, 1996, MOL PHARMACOL, V50, P781
[10]
GENOTYPE OR PHENOTYPE - THE DEFINITION OF A PHARMACOGENETIC POLYMORPHISM [J].
MEYER, UA .
PHARMACOGENETICS, 1991, 1 (02) :66-67